世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

米国のヘルスケアペイヤーにおけるビジネスプロセスAs A Serviceの市場規模、シェア、動向分析レポート:ソリューションカバレッジ別、バイヤータイプ別、バリューチェーンプロセス別、バイヤーサイズ別、セグメント別予測、2022年~2030年


U.S. Business Process As A Service In Healthcare Payers Market Size, Share & Trends Analysis Report By Solution Coverage, By Buyer Type, By Value Chain Processes, By Buyer Size, And Segment Forecasts, 2022 - 2030

米国ヘルスケアペイヤーにおけるBPO(Business Process As A Service)市場の成長・トレンド Grand View Research, Inc.の最新レポートによると、米国の医療費支払機関におけるサービスとしてのビジネスプロセ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2022年10月21日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報・注文方法はこちら
150 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

米国ヘルスケアペイヤーにおけるBPO(Business Process As A Service)市場の成長・トレンド

Grand View Research, Inc.の最新レポートによると、米国の医療費支払機関におけるサービスとしてのビジネスプロセスの市場規模は、2030年までに96億米ドルに達すると予測されています。2022年から2030年にかけての年平均成長率は6.0%で、市場は拡大すると予測されています。これは、BPaaSの契約が医療費支払機関のビジネスプロセスアウトソーシングの収益に大きく貢献したこと、COVID-19で急がれたバリューベースのケアへの移行により、支払機関のBPaaSの業界が拡大し、この割合が増加すると考えられるためです。

さらに、米国のペイバイダー業界におけるBPaaSの導入が急速に進んでいる。ペイバイダーは以前から存在したが、Affordable Care Actによってより一般的で重要な存在となったため、BPaaSの機会を活用するのに適している。

また、大手ペイプロバイダーの大半を除き、登録会員数でいえばまだかなりの規模に達していない。例えば、ロバート・ウッド・ジョンソン財団(RWJF)によると、2016年9月時点で、2010年以降に設立された42のプロバイダー・スポンサー・ヘルス・プラン(PSHP)のうち、保険加入者が5万~10万人だったのはわずか4つ、残りの36は5万人に満たないという。BPaaSソリューションは、プロバイダーにとってより迅速にスケールアップでき、長いタイムラグなしに導入しやすいため、これらの障害は十分に解決できる可能性があります。

さらに、業界特有の規制コンプライアンスでは、さまざまな産業分野のコンプライアンス要件が規定されています。医療保険の相互運用性と説明責任に関する法律(HIPAA)、経済的および臨床的健康のための医療情報技術(HITECH)、支払カード業界データセキュリティ基準(PCI DSS)は、この業界に影響を与えたいくつかの法律である。多くの場合、市場は現在、規制というよりむしろ管理活動としてコンプライアンス管理をサポートしています。BPaaSプロバイダーは、BPaaSソリューションを導入することで、業種間のコンプライアンスギャップを埋め、既存の規制の変更に対応することができるため、予測期間を通じて採用が増加し、業界の成長につながると考えられます。

米国の医療保険業者向けサービスとしてのビジネスプロセス市場のレポートハイライト

- 医療業界はここ数年で大きく発展しました。デジタルヘルスの台頭、バリューベースのケアへの移行、消費者主義の高まりは、すべて支払者の運営方法を変えています。従来のBPSアウトソーシングモデルは、プラットフォーム主導のBPaaSモデルへと急速に移行しつつあり、より優れたテクノロジーや人材へのアクセス、低コストでのデジタル変革の約束、所有コストの低減といったメリットがもたらされています。その結果、支払者の調達に関する考慮も進化しています。その結果、予測期間中、BPaaSの利用はCAGR 6.0%で緩やかに増加すると予想されます。

- 2021年には、中小規模の支払者が全支払者の70%以上を占め、BPaaSモデルをより強く好むようになると考えられる。プランタイプ別では、メディケアアドバンテージとマネージドメディケイドが有望なビジネスケースとして浮上しており、2021年にはMAが約29%の大きなシェアを占めることになる

- プロセスの観点では、クレーム管理などの管理プロセスが最もBPaaSの導入が進んでおり、2021年の売上シェアは30%超を占めている。しかし、医療費削減だけでなく、ケアマネジメント、ポピュレーションヘルスマネジメント、メンバーエンゲージメントなどのプロセスにおいても、支払者はBPaaSの可能性を徐々に認識するようになってきている。

- また、主要企業は、戦略的パートナーシップ、M&A、新サービスの提供を通じて、市場の拡大に貢献しています。例えば、コグニザントは2017年に、米国のメディケアパートD、マネージドメディケイド、MA市場向けのBPaaSの主要な国内プロバイダーであり、50州すべてで440万人以上の会員が提供する32のヘルスプランをサポートしていたTMG Healthを買収したと発表しています。TMG Healthの買収により、コグニザントは米国政府が運営する管理医療プログラムの主要サービスプロバイダーとしての地位を確固たるものにしました。



ページTOPに戻る


目次

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Mixed Approach Analysis (Model 1)
1.6.1.1 Approach 1: Mixed Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Summary, 2021
Chapter 3 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraints Analysis
3.4 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Analysis Tools: Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Threat Of Substitues
3.4.4 Threat Of New Entrants
3.4.5 Competitive Rivalry
3.5 PESTEL Analysis
3.5.1 Political & Legal Landscape
3.5.2 Social Landscape
3.5.3 Technology Landscape
3.5.4 Envirnomental Analysis
3.6 Regulatory Framework
3.7 Covid-19 Impact Analysis
3.7.1 Current And Future Impact Analysis
3.7.2 Impact OF Covid-19 On Market Players
Chapter 4 Competitive Landscape
4.1 Market participation categorization
4.2 Competitive Dashboard Analysis
4.3 Public Companies
4.3.1 Company Market Position Analysis
4.3.2 Synergy Analysis: Major Deals & Strategic Alliances
4.4 Detailed list of market players
Chapter 5 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Segment Analysis, by solution coverage, 2017 - 2030 (USD Billion)
5.1 Solution Coverage Movement Analysis, 2021 & 2030
5.1.1 Traditional BPaaS
5.1.1.1 Traditional BPaaS market estimates and forecasts, 2017 - 2030 (Billion)
5.1.2 Best-of-breed BPaaS
5.1.2.1 Best-of-breed BPaaS market estimates and forecasts, 2017 - 2030 (Billion)
Chapter 6 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Segment Analysis, by traditional BPaaS, 2017 - 2030 (USD Billion)
6.1 Traditional BPaaS Movement Analysis, 2021 & 2030
6.1.1 End-to-end (E2E) traditional BPaaS
6.1.1.1 End-to-end (E2E) traditional BPaaS market estimates and forecasts, 2017 - 2030 (Billion)
6.1.2 Process-specific traditional BPaaS
6.1.2.1 Process-specific traditional BPaaS market estimates and forecasts, 2017 - 2030 (Billion)
Chapter 7 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Segment Analysis, by best-of-breed BPaaS, 2017 - 2030 (USD Billion)
7.1 Best-of-breed BPaaS Movement Analysis, 2021 & 2030
7.1.1 End-to-end best-of-breed BPaaS
7.1.1.1 End-to-end best-of-breed BPaaS market estimates and forecasts, 2017 - 2030 (Billion)
7.1.2 Process-specific best-of-breed BPaaS
7.1.2.1 Process-specific best-of-breed BPaaS market estimates and forecasts, 2017 - 2030 (Billion)
Chapter 8 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Segment Analysis, by buyer type, 2017 - 2030 (USD Billion)
8.1 Buyer type Movement Analysis, 2021 & 2030
8.1.1 Government buyers
8.1.1.1 Government buyers’ market estimates and forecasts, 2017 - 2030 (Billion)
8.1.2 Commercial buyers
8.1.2.1 Commercial buyers’ market estimates and forecasts, 2017 - 2030 (Billion)
Chapter 9 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Segment Analysis, by commercial buyers, 2017 - 2030 (USD Billion)
9.1 Commercial Buyers Movement Analysis, 2021 & 2030
9.1.1 Medicare advantage
9.1.1.1 Medicare advantage market estimates and forecasts, 2017 - 2030 (Billion)
9.1.2 Managed Medicaid
9.1.2.1 Managed Medicaid market estimates and forecasts, 2017 - 2030 (Billion)
9.1.3 Individual health plan
9.1.3.1 Individual health plan market estimates and forecasts, 2017 - 2030 (Billion)
9.1.4 Employer-sponsored health plan
9.1.4.1 Employer-sponsored health plan market estimates and forecasts, 2017 - 2030 (Billion)
Chapter 10 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Segment Analysis, by value chain processes, 2017 - 2030 (USD Billion)
10.1 Value Chain Processes Movement Analysis, 2021 & 2030
10.1.1 Claims Management
10.1.1.1 Claims Management market estimates and forecasts, 2017 - 2030 (Billion)
10.1.2 Member Engagement
10.1.2.1 Member Engagement market estimates and forecasts, 2017 - 2030 (Billion)
10.1.3 Care Management
10.1.3.1 Care Management market estimates and forecasts, 2017 - 2030 (Billion)
10.1.4 Others (Product development, Network Management, Risk & Compliance)
10.1.4.1 Others market estimates and forecasts, 2017 - 2030 (Billion)
Chapter 11 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Segment Analysis, by buyer size, 2017 - 2030 (USD Billion)
11.1 Buyer Size Movement Analysis, 2021 & 2030
11.1.1 Small buyers
11.1.1.1 Small buyers’ market estimates and forecasts, 2017 - 2030 (Billion)
11.1.2 Midsized buyers
11.1.2.1 Midsized buyers’ market estimates and forecasts, 2017 - 2030 (Billion)
11.1.3 Large buyers
11.1.3.1 Large buyers’ market estimates and forecasts, 2017 - 2030 (Billion)
Chapter 12 Company Profiles
12.1 Accenture
12.1.1 Company Overview
12.1.2 Financial Performance
12.1.3 Product Benchmarking
12.1.4 Strategic Initiatives
12.2 Cognizant
12.2.1 Company Overview
12.2.2 Financial Performance
12.2.3 Product Benchmarking
12.2.4 Strategic Initiatives
12.3 HCL
12.3.1 Company Overview
12.3.2 Financial Performance
12.3.3 Product Benchmarking
12.3.4 Strategic Initiatives
12.4 IBM
12.4.1 Company Overview
12.4.2 Financial Performance
12.4.3 Product Benchmarking
12.4.4 Strategic Initiatives
12.5 Infosys
12.5.1 Company Overview
12.5.2 Financial Performance
12.5.3 Product Benchmarking
12.5.4 Strategic Initiatives
12.6 NTT DATA
12.6.1 Company Overview
12.6.2 Financial Performance
12.6.3 Product Benchmarking
12.6.4 Strategic Initiatives
12.7 Optum
12.7.1 Company Overview
12.7.2 Financial Performance
12.7.3 Product Benchmarking
12.7.4 Strategic Initiatives
12.8 TCS
12.8.1 Company Overview
12.8.2 Financial Performance
12.8.3 Product Benchmarking
12.8.4 Strategic Initiatives
12.9 UST
12.9.1 Company Overview
12.9.2 Financial Performance
12.9.3 Product Benchmarking
12.9.4 Strategic Initiatives
12.10 Wipro
12.10.1 Company Overview
12.10.2 Financial Performance
12.10.3 Product Benchmarking
12.10.4 Strategic Initiatives
12.11 EXL
12.11.1 Company Overview
12.11.2 Financial Performance
12.11.3 Product Benchmarking
12.11.4 Strategic Initiatives
12.12 Softheon
12.12.1 Company Overview
12.12.2 Financial Performance
12.12.3 Product Benchmarking
12.12.4 Strategic Initiatives
12.13 Genpact
12.13.1 Company Overview
12.13.2 Financial Performance
12.13.3 Product Benchmarking
12.13.4 Strategic Initiatives
12.14 Change Healthcare
12.14.1 Company Overview
12.14.2 Financial Performance
12.14.3 Product Benchmarking
12.14.4 Strategic Initiatives
12.15 Firstsource
12.15.1 Company Overview
12.15.2 Financial Performance
12.15.3 Product Benchmarking
12.15.4 Strategic Initiatives
12.16 Celegence
12.16.1 Company Overview
12.16.2 Financial Performance
12.16.3 Product Benchmarking
12.16.4 Strategic Initiatives

 

ページTOPに戻る


 

Summary

U.S. Business Process As A Service In Healthcare Payers Market Growth & Trends

The U.S. business process as a service in healthcare payers market size is expected to reach USD 9.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.0% from 2022 to 2030. As a result of the fact that BPaaS engagements contributed significantly to healthcare payer business process outsourcing revenue and that this percentage is likely to rise as the industry for payer BPaaS expands due to the move toward value-based care, which has been hastened by COVID-19.

Furthermore, the adoption of BPaaS in the U.S. payviders industry is growing quickly. Although payviders have been around for a while, the Affordable Care Act made them more common and significant, which makes them well-suited to take advantage of the BPaaS opportunity.

In addition, many have not attained considerable scale in terms of members registered, except the majority of large payviders. For instance, according to The Robert Wood Johnson Foundation (RWJF) as of September 2016, just 4 of the 42 Provider Sponsored Health Plans (PSHPs) established since 2010 had between 50,000 and 100,000 covered subscribers, with the remaining 36 having fewer than 50,000. These obstacles could well be solved since BPaaS solutions scale more quickly for the provider and are easier to install without a long lag time.

Additionally, industry-specific regulatory compliances specify a range of compliance requirements for various industrial verticals. The Health Insurance Portability and Accountability Act (HIPAA), the Health Information Technology for Economic and Clinical Health (HITECH), and the Payment Card Industry Data Security Standard (PCI DSS) are a few legislations that have impacted the industry. In many instances, the market now supports compliance management as an administrative activity rather than a regulatory one. A BPaaS provider could implement BPaaS solutions that can bridge compliance gaps between verticals and adapt to changes in the existing regulations, leading to the industry’s growth with the rise in adoption throughout the forecast period—as all compliance adherence difficulties can be managed with their assistance.

U.S. Business Process As A Service In Healthcare Payers Market Report Highlights

• The healthcare industry has advanced significantly over the last few years. The rise of digital health, the shift to value-based care, and rising consumerism have all altered how payers operate. The traditional BPS outsourcing model is quickly giving way to a platform-led BPaaS model, which has brought about advantages like access to better technology and human capital, the promise of digital transformation at a lower cost, and a lower cost of ownership. As a result, payers' sourcing considerations have also evolved. As a consequence, throughout the forecast period, BPaaS usage is anticipated to increase moderately at a CAGR of 6.0%

• Small and medium-sized payers, make up more than 70% of all payers in 2021 and have shown a stronger preference for the BPaaS model. In terms of plan types, medicare advantage and managed Medicaid have emerged as viable business cases, with MA accounting for a significant share percentage of about 29% in 2021

• From a process perspective, administrative processes like claims management have seen the most BPaaS adoption, accounting for over 30% of the revenue share in 2021. Payers are, however, progressively becoming aware of BPaaS's potential in processes like care management, population health management, and member engagement as well as in reducing medical expenses

• Key players also contribute to the market's expansion through strategic partnerships, mergers, and acquisitions, as well as the introduction of new offerings. For instance, Cognizant announced in 2017 that it had acquired TMG Health, a key national provider of BPaaS to the Medicare Part D, Managed Medicaid, and MA markets in the U.S., which supported 32 health plans offered with more than 4.4 million members across all 50 states. Through the purchase of TMG Health, Cognizant solidifies its position as the leading service provider for management health programs run by the U.S. government



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Mixed Approach Analysis (Model 1)
1.6.1.1 Approach 1: Mixed Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Summary, 2021
Chapter 3 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraints Analysis
3.4 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Analysis Tools: Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Threat Of Substitues
3.4.4 Threat Of New Entrants
3.4.5 Competitive Rivalry
3.5 PESTEL Analysis
3.5.1 Political & Legal Landscape
3.5.2 Social Landscape
3.5.3 Technology Landscape
3.5.4 Envirnomental Analysis
3.6 Regulatory Framework
3.7 Covid-19 Impact Analysis
3.7.1 Current And Future Impact Analysis
3.7.2 Impact OF Covid-19 On Market Players
Chapter 4 Competitive Landscape
4.1 Market participation categorization
4.2 Competitive Dashboard Analysis
4.3 Public Companies
4.3.1 Company Market Position Analysis
4.3.2 Synergy Analysis: Major Deals & Strategic Alliances
4.4 Detailed list of market players
Chapter 5 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Segment Analysis, by solution coverage, 2017 - 2030 (USD Billion)
5.1 Solution Coverage Movement Analysis, 2021 & 2030
5.1.1 Traditional BPaaS
5.1.1.1 Traditional BPaaS market estimates and forecasts, 2017 - 2030 (Billion)
5.1.2 Best-of-breed BPaaS
5.1.2.1 Best-of-breed BPaaS market estimates and forecasts, 2017 - 2030 (Billion)
Chapter 6 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Segment Analysis, by traditional BPaaS, 2017 - 2030 (USD Billion)
6.1 Traditional BPaaS Movement Analysis, 2021 & 2030
6.1.1 End-to-end (E2E) traditional BPaaS
6.1.1.1 End-to-end (E2E) traditional BPaaS market estimates and forecasts, 2017 - 2030 (Billion)
6.1.2 Process-specific traditional BPaaS
6.1.2.1 Process-specific traditional BPaaS market estimates and forecasts, 2017 - 2030 (Billion)
Chapter 7 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Segment Analysis, by best-of-breed BPaaS, 2017 - 2030 (USD Billion)
7.1 Best-of-breed BPaaS Movement Analysis, 2021 & 2030
7.1.1 End-to-end best-of-breed BPaaS
7.1.1.1 End-to-end best-of-breed BPaaS market estimates and forecasts, 2017 - 2030 (Billion)
7.1.2 Process-specific best-of-breed BPaaS
7.1.2.1 Process-specific best-of-breed BPaaS market estimates and forecasts, 2017 - 2030 (Billion)
Chapter 8 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Segment Analysis, by buyer type, 2017 - 2030 (USD Billion)
8.1 Buyer type Movement Analysis, 2021 & 2030
8.1.1 Government buyers
8.1.1.1 Government buyers’ market estimates and forecasts, 2017 - 2030 (Billion)
8.1.2 Commercial buyers
8.1.2.1 Commercial buyers’ market estimates and forecasts, 2017 - 2030 (Billion)
Chapter 9 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Segment Analysis, by commercial buyers, 2017 - 2030 (USD Billion)
9.1 Commercial Buyers Movement Analysis, 2021 & 2030
9.1.1 Medicare advantage
9.1.1.1 Medicare advantage market estimates and forecasts, 2017 - 2030 (Billion)
9.1.2 Managed Medicaid
9.1.2.1 Managed Medicaid market estimates and forecasts, 2017 - 2030 (Billion)
9.1.3 Individual health plan
9.1.3.1 Individual health plan market estimates and forecasts, 2017 - 2030 (Billion)
9.1.4 Employer-sponsored health plan
9.1.4.1 Employer-sponsored health plan market estimates and forecasts, 2017 - 2030 (Billion)
Chapter 10 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Segment Analysis, by value chain processes, 2017 - 2030 (USD Billion)
10.1 Value Chain Processes Movement Analysis, 2021 & 2030
10.1.1 Claims Management
10.1.1.1 Claims Management market estimates and forecasts, 2017 - 2030 (Billion)
10.1.2 Member Engagement
10.1.2.1 Member Engagement market estimates and forecasts, 2017 - 2030 (Billion)
10.1.3 Care Management
10.1.3.1 Care Management market estimates and forecasts, 2017 - 2030 (Billion)
10.1.4 Others (Product development, Network Management, Risk & Compliance)
10.1.4.1 Others market estimates and forecasts, 2017 - 2030 (Billion)
Chapter 11 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Segment Analysis, by buyer size, 2017 - 2030 (USD Billion)
11.1 Buyer Size Movement Analysis, 2021 & 2030
11.1.1 Small buyers
11.1.1.1 Small buyers’ market estimates and forecasts, 2017 - 2030 (Billion)
11.1.2 Midsized buyers
11.1.2.1 Midsized buyers’ market estimates and forecasts, 2017 - 2030 (Billion)
11.1.3 Large buyers
11.1.3.1 Large buyers’ market estimates and forecasts, 2017 - 2030 (Billion)
Chapter 12 Company Profiles
12.1 Accenture
12.1.1 Company Overview
12.1.2 Financial Performance
12.1.3 Product Benchmarking
12.1.4 Strategic Initiatives
12.2 Cognizant
12.2.1 Company Overview
12.2.2 Financial Performance
12.2.3 Product Benchmarking
12.2.4 Strategic Initiatives
12.3 HCL
12.3.1 Company Overview
12.3.2 Financial Performance
12.3.3 Product Benchmarking
12.3.4 Strategic Initiatives
12.4 IBM
12.4.1 Company Overview
12.4.2 Financial Performance
12.4.3 Product Benchmarking
12.4.4 Strategic Initiatives
12.5 Infosys
12.5.1 Company Overview
12.5.2 Financial Performance
12.5.3 Product Benchmarking
12.5.4 Strategic Initiatives
12.6 NTT DATA
12.6.1 Company Overview
12.6.2 Financial Performance
12.6.3 Product Benchmarking
12.6.4 Strategic Initiatives
12.7 Optum
12.7.1 Company Overview
12.7.2 Financial Performance
12.7.3 Product Benchmarking
12.7.4 Strategic Initiatives
12.8 TCS
12.8.1 Company Overview
12.8.2 Financial Performance
12.8.3 Product Benchmarking
12.8.4 Strategic Initiatives
12.9 UST
12.9.1 Company Overview
12.9.2 Financial Performance
12.9.3 Product Benchmarking
12.9.4 Strategic Initiatives
12.10 Wipro
12.10.1 Company Overview
12.10.2 Financial Performance
12.10.3 Product Benchmarking
12.10.4 Strategic Initiatives
12.11 EXL
12.11.1 Company Overview
12.11.2 Financial Performance
12.11.3 Product Benchmarking
12.11.4 Strategic Initiatives
12.12 Softheon
12.12.1 Company Overview
12.12.2 Financial Performance
12.12.3 Product Benchmarking
12.12.4 Strategic Initiatives
12.13 Genpact
12.13.1 Company Overview
12.13.2 Financial Performance
12.13.3 Product Benchmarking
12.13.4 Strategic Initiatives
12.14 Change Healthcare
12.14.1 Company Overview
12.14.2 Financial Performance
12.14.3 Product Benchmarking
12.14.4 Strategic Initiatives
12.15 Firstsource
12.15.1 Company Overview
12.15.2 Financial Performance
12.15.3 Product Benchmarking
12.15.4 Strategic Initiatives
12.16 Celegence
12.16.1 Company Overview
12.16.2 Financial Performance
12.16.3 Product Benchmarking
12.16.4 Strategic Initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Grand View Research 社の最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/05 10:26

162.17 円

175.82 円

209.73 円

ページTOPに戻る